Shopping Cart
Remove All
Your shopping cart is currently empty
ERα degrader7 (Compound B1) is a potent ERα degrader, exhibiting an IC50 of 14.6 nM and a DC50 of 9.7 nM. This compound demonstrates excellent antitumor activity, indicating its potential as a selective estrogen receptor degrader (SERD) for breast cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | ERα degrader7 (Compound B1) is a potent ERα degrader, exhibiting an IC50 of 14.6 nM and a DC50 of 9.7 nM. This compound demonstrates excellent antitumor activity, indicating its potential as a selective estrogen receptor degrader (SERD) for breast cancer research. |
| In vitro | ERα degrader 7 exhibits antitumor activity against breast cancer cells (IC50 = 4.21 nM) without cytotoxic effects on normal breast epithelial cells at concentrations of 10-5 to 10 μM over a period of 5 days. Additionally, ERα degrader 7 (50-1000 nM, 5 d) demonstrates significant concentration-dependent degradation of ERα in MCF-7 cells. |
| Formula | C28H24F4N2O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.